USPTO Examiner WRUBLESKI MATTHEW JAMES - Art Unit 3781

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19348908Systems and Methods for Endothelial Regeneration of Schlemm's CanalOctober 2025January 2026Allow401YesNo
18758303CONVEX OSTOMY BARRIER AND METHOD OF FORMING CONVEX OSTOMY BARRIERS OF VARIOUS SOFTNESSJune 2024January 2026Allow1920YesNo
18675814METHOD FOR AUTOMATED PRIMING OF AN EXTRACORPOREAL BLOOD CONDUIT SYSTEM, AND A DEVICE FOR SAMEMay 2024December 2025Abandon1810NoNo
18666320Vial Adapter and Injection Kit for Withdrawing a Liquid Medicament from an Injection VialMay 2024March 2025Allow1021YesNo
18610523FLUID COLLECTION ASSEMBLIES INCLUDING A POROUS MATERIAL HAVING A FIRST POROUS LAYER, A SECOND POROUS LAYER, AND A SUPPORTING LAYERMarch 2024March 2026Allow2300NoNo
18442214URINARY CATHETER ASSEMBLY INCLUDING A CATHETERIZATION AID PROVIDING A HANDLE AND AN INTERMITTENT CATHETER DISPOSED WITHIN THE HANDLEFebruary 2024June 2025Allow1620YesNo
18398099FLUID MANAGEMENT SYSTEMS AND METHODSDecember 2023January 2025Allow1210YesNo
18556928OSTOMY POUCH WITH VIEWING OPTION FEATUREOctober 2023February 2025Allow1620YesNo
18362075Overnight Urinal DeviceJuly 2023March 2026Abandon3110NoNo
18213227SYSTEM AND APPARATUS FOR PREVENTING THERAPY UNIT CONTAMINATIONJune 2023February 2024Allow700NoNo
18036013NEGATIVE-PRESSURE THERAPY DRESSING WITH EXPANDABLE DEPTHMay 2023March 2026Allow3440YesNo
18141959NEGATIVE PRESSURE WOUND THERAPY APPARATUS AND METHODSMay 2023February 2026Allow3410NoNo
18028600OSTOMY PRODUCT WITH ANTI-REFLUX DEVICEMarch 2023June 2025Allow2700YesNo
18124340NASAL COMPRESSION DEVICEMarch 2023October 2025Allow3110NoNo
18117006METHODS AND INTERFACES FOR PROVIDING DONATION PROCESS FEEDBACKMarch 2023November 2025Allow3311NoNo
18116999Apheresis System Safety FeaturesMarch 2023February 2026Allow3611YesNo
18017980RENAL FAILURE THERAPY SYSTEMS HAVING REDUCED TIME BETWEEN TREATMENTSJanuary 2023September 2025Allow3200YesNo
18070911TYMPANOSTOMY TUBE AND PLACEMENT DEVICENovember 2022March 2026Allow3930YesNo
17998832MOBILE NEGATIVE PRESSURE WOUND THERAPY DEVICE CONFIGURED FOR START-UP TESTNovember 2022June 2024Allow1910NoNo
17938593SYSTEMS AND METHODS FOR RELEASING NANOSPHERE PARTICLES WITHIN A CATHETER PUMP ASSEMBLY AND REDUCING A FLUID PRESSURE THEREOFOctober 2022February 2026Abandon4010NoNo
17938224FLUID DRUG SPREAD-PROMOTING PUMPOctober 2022August 2024Allow2220NoNo
17936685NEURAL NETWORK-AIDED ASPIRATION THROMBECTOMY SYSTEM AND METHODS FOR THROMBUS REMOVALSeptember 2022November 2025Allow3720YesNo
17913139SYSTEM FOR DETECTING BLOOD IN A DIALYSATE FLOW OF A DIALYSIS MACHINESeptember 2022May 2025Allow3100NoNo
17800327Adaptor for a Medical Container and a Medical Container Comprising Said AdaptorAugust 2022July 2025Allow3520NoNo
17886038BIOLOGICAL COMPONENT CASSETTE, BIOLOGICAL COMPONENT KIT, AND BIOLOGICAL COMPONENT TREATMENT SYSTEMAugust 2022February 2026Allow4311NoNo
17876187WOUND TREATMENT DEVICEJuly 2022October 2024Allow2740YesNo
17814537METHOD OF OPERATION FOR PROCESSING OF BLOOD TO NEUTRALIZE PATHOGEN CELLS THEREINJuly 2022October 2025Allow3910NoNo
17812515MONITORING RECIRCULATIONJuly 2022August 2025Allow3820YesNo
17862103DEVICE TO DIRECT URINE STREAMJuly 2022September 2023Abandon1410NoNo
17854021MEDICAL FLUID PUMP WITH A CARRYING HANDLE AND SUPPORTING OR HOLDING DEVICE FOR A MEDICAL FLUID PUMPJune 2022September 2025Allow3920NoNo
17850444External Female Gravity-Based DrainageJune 2022July 2025Allow3750NoNo
17808354URINE COLLECTION SYSTEMS HAVING ONE OR MORE OF VOLUME, PRESSURE, OR FLOW INDICATORS, AND RELATED METHODSJune 2022November 2025Allow4140YesNo
17788110COMPOSITIONS, DEVICES AND METHODS FOR DIAGNOSING AND TREATING INFECTIOUS DISEASEJune 2022April 2025Abandon3410NoNo
17843453AUTOMATED BODY FLUID DRAIN CONTROL APPARATUS WITH ONE OR MORE CAMERASJune 2022October 2025Abandon4031NoNo
17784184DEVICE AND KIT FOR PREVENTING TOXIC AEROSOL OF A DRUG FROM SPREADING IN THE ENVIRONMENT AND METHOD FOR THEIR USEJune 2022November 2025Abandon4111NoNo
17781552DRESSING WITH SPACER FABRIC TO PROMOTE MEDIAL TENSIONJune 2022October 2024Allow2930YesNo
17752972Burn Treatment GloveMay 2022December 2023Abandon1920NoNo
17779095CONFORMABLE DRESSING FOR NEGATIVE-PRESSURE TREATMENT OF LARGE AREASMay 2022December 2024Abandon3110NoNo
17777110VACUUM DRESSING FOR USE WITH GUIDE TUBEMay 2022December 2025Abandon4310NoNo
17663330FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE INFLATION DEVICE AND METHODS AND SYSTEMS OF USING THE SAMEMay 2022November 2024Allow3030NoNo
17661090FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE LENGTH ADJUSTING FEATUREApril 2022October 2024Allow3030YesNo
17755436OCULAR DRUG DELIVERY DEVICESApril 2022December 2025Allow4430YesNo
17709276HEART RATE SYNCHRONOUS ASPIRATION SYSTEM AND METHOD FOR TREATMENT OF ISCHEMIC STROKEMarch 2022September 2025Allow4210YesNo
17701530APPLICATOR FOR A MENSTRUAL DEVICEMarch 2022March 2025Abandon3631NoNo
17697424Antimicrobial Diapering DeviceMarch 2022May 2025Abandon3820NoNo
17640597Printed Delivery Device Having SupplementsMarch 2022February 2025Abandon3510NoNo
17677002Body-Worn Therapeutic DeviceFebruary 2022January 2024Abandon2310NoNo
17676028Liquid and Waste Collection SystemFebruary 2022February 2026Allow4850YesNo
17634210Gel-Blocking Connection Assembly For Absorbent Negative Pressure DressingFebruary 2022April 2024Allow2621YesNo
17667060Skin Protection DeviceFebruary 2022October 2023Abandon2010NoNo
17630842Hand Dressing For Use With Negative Pressure Wound Therapy, Negative Pressure Wound Therapy System Comprising The Same, Method For Controlling A Pump Coupled To Said DressingJanuary 2022February 2026Abandon4801NoNo
17629721Dressing With Epithelialization And Scar Reduction FeatureJanuary 2022July 2024Allow3030NoNo
17578777ADMINISTRABLE LIQUID MEDICINE PREPARATION TOOL, ADMINISTRABLE LIQUID MEDICINE PREPARATION KIT, AND ADMINISTRABLE LIQUID MEDICINE PREPARATION METHOD USING THE SAMEJanuary 2022June 2025Allow4010YesNo
17569569TRAINING PANTS WITH GRAPHICSJanuary 2022July 2024Abandon3030NoNo
17565840WOUND DRESSING AND METHOD OF USEDecember 2021June 2025Allow4230YesNo
17565346WOUND DRESSING AND METHOD OF USEDecember 2021July 2025Allow4330YesNo
17565334WOUND DRESSING AND METHOD OF USEDecember 2021July 2025Allow4330YesNo
17535144System For Monitoring Compliant Usage Of Negative Pressure Wound TherapyNovember 2021February 2025Allow3930NoNo
17527456MULTI CATHETER METHOD OF PERFORMING A ROBOTIC NEUROVASCULAR PROCEDURENovember 2021October 2025Allow4720YesNo
17611606VENTRICULOAMNIOTIC SHUNT FOR FETAL AQUEDUCTAL STENOSISNovember 2021August 2025Allow4530NoNo
17526992OPTIMIZING POWER TRANSFER TO NEGATIVE PRESSURE SOURCES IN NEGATIVE PRESSURE THERAPY SYSTEMSNovember 2021January 2025Allow3910NoNo
17606129Wound Therapy System With HumidifierOctober 2021January 2024Allow2720NoNo
17501591FLUID COLLECTION ASSEMBLIES INCLUDING AT LEAST ONE OF A PROTRUSION OR AT LEAST ONE EXPANDABLE MATERIALOctober 2021July 2024Allow3320NoNo
17501739LAVAGE SYSTEMS AND DEVICES HAVING WARMING COMPONENTOctober 2021August 2024Allow3431YesNo
17500331Microrobot Controlling Drug Release By Sound Waves And Method Of Manufacturing The MicrorobotOctober 2021March 2025Abandon4160NoNo
17493372EXTENDED RELEASE DEVICES AND THERAPEUTICS FOR LONG TERM TREATMENT OF URINARY TRACT INFECTION IN-VIVOOctober 2021September 2024Abandon3620NoYes
17490163ADVANCED ILEOSTOMY SUPPORT SYSTEMSeptember 2021November 2023Abandon2510NoNo
17442023ABSORBENT DRESSING WITH REMOTE MEASUREMENT OF DRESSING MOISTURESeptember 2021October 2025Allow4960YesNo
17481554Fluid Container Devices, Methods and SystemsSeptember 2021June 2024Allow3310YesNo
17440278BIOMEDICAL CONNECTING DEVICE FOR MEASURING BLOOD PRESSURESeptember 2021September 2024Abandon3610NoNo
17439167SURGICAL AUXILIARY EQUIPMENT FOR SUTURELESS CLOSED SKIN INCISION IN DEEP FASCIA LIMBSSeptember 2021August 2024Abandon3510NoNo
17474961IMPLANT FOR LOCAL ACTIVE INGREDIENT RELEASESeptember 2021July 2024Allow3430YesNo
17593209SURGICAL AID DEVICE FOR SUTURELESS CLOSURE OF SKIN WOUND IN SUPERFICIAL FASCIA OF SKINSeptember 2021August 2024Abandon3510NoNo
17593218NEGATIVE PRESSURE DRAINAGE AND CLEANING SYSTEM FOR SUTURELESS CLOSING OF SKIN INCISIONSSeptember 2021January 2024Abandon2920NoNo
17435388BLOOD BAG SYSTEM WITH MULTIPLE LOCKING CLAMPAugust 2021October 2024Abandon3810NoNo
17433604A Urinary Catheterisation AidAugust 2021November 2023Allow2711YesNo
16465395INTRAOSSEOUS PRESSURE RELEASE SCREWAugust 2021August 2025Allow6011NoNo
17445587PORTABLE URINARY AID DEVICEAugust 2021August 2023Abandon2410NoNo
17432697BLOOD BAG SYSTEM AND CLAMPAugust 2021October 2024Abandon3810NoNo
17398671NEGATIVE-PRESSURE THERAPY WITH PNEUMATICALLY-ACTUATED INSTILLATIONAugust 2021August 2024Allow3710NoNo
17444235MEDICINE POWDER DELIVERY DEVICE AND MEDICINE BOTTLE THEREOF AND BOTTLE CAP OF MEDICINE BOTTLEAugust 2021May 2025Allow4520NoNo
17425075FECAL DISCHARGE COLLECTION DEVICEJuly 2021May 2024Allow3430YesNo
17424922DELIVERY SYSTEM FOR FECAL MANAGEMENT DEVICEJuly 2021January 2024Allow3010NoNo
17372252WOUND DRESSING AND METHOD OF USEJuly 2021July 2025Allow4840YesNo
17415377EXTRACORPOREAL BLOOD CIRCULATION SYSTEM PROVIDED WITH BLOOD PURIFICATION DEVICE AND BLOOD COMPONENT ADJUSTERJune 2021January 2025Abandon4320NoNo
17413834GLAUCOMA IMPLANT DEVICEJune 2021July 2023Abandon2510NoNo
17311874PERFORMANCE MONITORING OF REGIONAL CITRATE ANTICOAGULATIONJune 2021June 2024Allow3610YesNo
17340365DISPOSABLE ABSORBENT PANT HAVING DISCREET CARRY AND DISPOSAL POCKETJune 2021July 2024Abandon3740NoNo
17296992BAG FOR SOLID CONCENTRATEMay 2021April 2025Allow4620YesNo
17292662System And Apparatus For Preventing Therapy Unit ContaminationMay 2021March 2023Allow2210NoNo
17237365CEREBRAL SPINAL FLUID SHUNT PLUGApril 2021August 2024Allow4010YesNo
17286846TAMPER EVIDENT TRANSDERMAL PATCHApril 2021September 2024Abandon4110NoNo
17269819BLOOD PURIFICATION DEVICEFebruary 2021May 2024Allow3920YesNo
17267405METHOD FOR DETECTION OF FLOW OBSTRUCTION IN AN EXTRACORPOREAL CIRCUIT, APPARATUS AND COMPUTER PROGRAMFebruary 2021February 2025Allow4830NoNo
17168829Fluid Management Systems and MethodsFebruary 2021August 2023Allow3001NoNo
17265110CONNECTING DEVICE CONFIGURED TO CONNECT A CONTAINER TO A VIALFebruary 2021May 2024Abandon3910NoNo
17263039CONVEX OSTOMY BARRIER AND METHOD OF FORMING CONVEX OSTOMY BARRIERS OF VARIOUS SOFTNESSJanuary 2021April 2024Allow3810NoNo
17133218AUTOMATED FLUID INFUSION CONTROL FOR CIRCULATORY SUPPORT AND ECMO SYSTEMSDecember 2020December 2024Allow4840YesNo
17254896METHOD FOR AUTOMATED PRIMING OF AN EXTRACORPOREAL BLOOD CONDUIT SYSTEM, AND A DEVICE FOR SAMEDecember 2020March 2024Allow3910NoNo
17252794FOLDED ABSORBENT ARTICLEDecember 2020April 2024Abandon4010NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WRUBLESKI, MATTHEW JAMES.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
1
(100.0%)
Filing Benefit Percentile
10.9%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner WRUBLESKI, MATTHEW JAMES - Prosecution Strategy Guide

Executive Summary

Examiner WRUBLESKI, MATTHEW JAMES works in Art Unit 3781 and has examined 52 patent applications in our dataset. With an allowance rate of 61.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.

Allowance Patterns

Examiner WRUBLESKI, MATTHEW JAMES's allowance rate of 61.5% places them in the 22% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by WRUBLESKI, MATTHEW JAMES receive 1.96 office actions before reaching final disposition. This places the examiner in the 49% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by WRUBLESKI, MATTHEW JAMES is 39 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +58.8% benefit to allowance rate for applications examined by WRUBLESKI, MATTHEW JAMES. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 38.6% of applications are subsequently allowed. This success rate is in the 88% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 22.2% of cases where such amendments are filed. This entry rate is in the 29% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 49% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 6.2% of allowed cases (in the 83% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.